Your only mesothelioma lung news source!
Click on each item to read full story.

 
Mesothelioma: New Findings On Treatment Options
read story
Treating patients with high-dose radiotherapy after chemotherapy and surgery for malignant pleural mesothelioma does not achieve improvements in local relapse and overall survival, according to new data from a prospective randomized phase II trial.
 
Studies report new findings on treatment options for mesothelioma
read story
( European Society for Medical Oncology ) Treating patients with high-dose radiotherapy after chemotherapy and surgery for malignant pleural mesothelioma does not achieve improvements in local relapse and overall survival, according to data from a prospective randomized phase II trial presented at ESMO 2014 Congress in Madrid.
 
PD-L1 protein could be a potential immunotherapy target for malignant pleural mesothelioma
read story
Treating patients with high-dose radiotherapy after chemotherapy and surgery for malignant pleural mesothelioma does not achieve improvements in local relapse and overall survival, according to data from a prospective randomized phase II trial presented at ESMO 2014 Congress in Madrid.
 
Deadly Cancer Gets Media Coverage on Awareness Day
read story
On September 26th, Mesothelioma Awareness Day, the Mesothelioma Applied Research Foundation (Meso Foundation) and its volunteers received media coverage to shed light on this deadly cancer. (PRWeb September 30, 2014) Read the full story at http://www.prweb.com/releases/2014/10/prweb12213742.htm
 
Video of Philadelphia Regional Conference on Mesothelioma Now Available Online
read story
The Mesothelioma Applied Research Foundation (Meso Foundation), in collaboration with Penn’s Abramson Cancer Center, held a regional conference on mesothelioma on September 26 – video of presentations is now available for viewing online. (PRWeb September 30, 2014) Read the full story at http://www.prweb.com/releases/2014/10/prweb12212903.htm
 
Curcumin, cancer-inhibiting peptides show promise in slowing progression of mesothelioma
read story
A common Asian spice and cancer-hampering molecules show promise in slowing the progression of mesothelioma, a cancer of the lung's lining often linked to asbestos. Scientists from Case Western Reserve University and the Georg-Speyer-Haus in Frankfurt, Germany, demonstrate that application of curcumin, a derivative of the spice turmeric, and cancer-inhibiting peptides increase levels of a ...
 
Curcumin, special peptides boost cancer-blocking PIAS3 to neutralize STAT3 in mesothelioma
read story
( Case Western Reserve University ) A common Asian spice and cancer-hampering molecules show promise in slowing the progression of mesothelioma, a cancer of the lung's lining often linked to asbestos. Scientists from Case Western Reserve University and the Georg-Speyer-Haus in Frankfurt, Germany, demonstrate that application of curcumin, a derivative of the spice turmeric, and cancer-inhibiting ...
 
Meso Foundation and University of Chicago Medicine Present Chicago Conference on Mesothelioma
read story
The Mesothelioma Applied Research Foundation (Meso Foundation) released the agenda for its regional conference held in collaboration with The University of Chicago Medicine, which will take place on October 10th at the Palmer House Hilton in Chicago and will feature area experts in the field of mesothelioma. (PRWeb September 30, 2014) Read the full story at http://www.prweb.com/releases/2014/10 ...
 
Curcumin, Special Peptides Boost Cancer-Blocking PIAS3 to Neutralize Cancer-Activating STAT3 in Mesothelioma
read story
A common Asian spice and cancer-hampering molecules show promise in slowing mesothelioma, cancer of the lung lining linked to asbestos. Scientists from Case Western Reserve and Georg-Speyer-Haus demonstrate curcumin and cancer-inhibiting peptides increase a protein inhibitor that slows mesothelioma.
 
New Study Finds Link Between Genes and Mesothelioma Location, Reports Surviving Mesothelioma
read story
Scientists say the chromosomes of asbestos-exposed people may influence what kind of mesothelioma they develop. (PRWeb September 19, 2014) Read the full story at http://www.prweb.com/releases/2014/09/prweb12181933.htm